- Delivering Pan India
Rybelsus® (Oral Semaglutide) Oral semaglutide 3 mg, 7 mg and 14 mg tablets by Novo Nordisk. Genuine stock supplied in bulk/wholesale quantities to hospitals and pharmacies across India by A.K. Pharma, a licensed pharmaceutical distributor in Delhi.
| Composition | Semaglutide 3 mg, 7 mg, 14 mg |
|---|---|
| Manufacturer | Novo Nordisk |
| Country | Denmark |
| Pack size | Blister pack |
| Storage | Store as stated on the carton, in the original blister pack |
Supplied only against a valid prescription from a registered medical practitioner.
Sourced from authorised channels
Temperature-controlled packing
Hospitals, clinics, pharmacies
Delhi drug licence holder
Rybelsus® (Oral Semaglutide) 3 mg, 7 mg and 14 mg Tablets: A Sourcing Guide for Hospitals and Pharmacies
Rybelsus® is an oral semaglutide tablet (GLP-1 receptor agonist) marketed by Novo Nordisk. The decision to prescribe semaglutide, including patient selection, dose and monitoring, rests entirely with the treating physician. This page provides sourcing and procurement information for hospitals and pharmacies, not clinical or treatment guidance.
As both a trusted medicine distributor in Delhi and a licensed pharmaceutical distributor in Delhi, A.K. Pharma supplies genuine Rybelsus® (oral semaglutide) 3 mg, 7 mg and 14 mg tablets to hospitals and pharmacies across India. Buyers comparing pharmaceutical distribution companies and wholesale pharmaceutical distributors can also browse our full product range and the Diabetes category. Supply is in bulk/wholesale quantities only.
Rybelsus contains semaglutide in an oral tablet form, in strengths of 3 mg, 7 mg and 14 mg as marketed in India. The US label also lists a newer tablet formulation in 1.5 mg, 4 mg and 9 mg strengths. Presentations on the Indian pack are those on the carton.
How it works, according to the label: The US prescribing information (DailyMed) describes semaglutide as a glucagon-like peptide-1 (GLP-1) receptor agonist.
The current US prescribing information for Rybelsus (DailyMed) lists the following. Indications in India may differ and are defined by the Indian regulator and the Rybelsus pack insert.
Published studies of oral semaglutide include the PIONEER programme (PIONEER 1 to 10) in type 2 diabetes, PIONEER 6 (N Engl J Med 2019) on cardiovascular safety and SOUL (N Engl J Med 2025) on cardiovascular outcomes. Results and conclusions are those of the trial authors and the prescribing information; A.K. Pharma does not interpret them.
| Strength | Dosage form | Pack (confirm against the carton) |
|---|---|---|
| Semaglutide 3 mg | Tablet | Blister pack (confirm against the carton) |
| Semaglutide 7 mg | Tablet | Blister pack (confirm against the carton) |
| Semaglutide 14 mg | Tablet | Blister pack (confirm against the carton) |
Please confirm the current pack and batch with us before ordering. Dose and regimen must be determined and followed exactly as directed by the treating physician and the approved prescribing information.
Hospitals, diabetology and endocrinology centres and pharmacies in India that need to source Rybelsus in bulk quantities from a licensed distributor.
Side effects are listed in the prescribing information and Indian pack insert and are not summarised here. The US label carries a boxed warning on the risk of thyroid C-cell tumours; refer to the label and consult the treating physician.
All use should follow the approved prescribing information and the instructions of the treating physician.
Store as directed on the carton, in the original blister pack to protect from moisture and light. The US label directs storage at 20°C to 25°C.
Rybelsus is marketed by Novo Nordisk. A.K. Pharma is a licensed distributor and does not manufacture the product. As one of the pharmaceutical distributors serving Indian hospitals, we source Rybelsus through authorised channels and supply it with pack and batch details. Buyers comparing a pharmaceutical wholesale distributors list or a pharma distribution company can verify our credentials on the About Us page.
Is Rybelsus available in India?
A.K. Pharma supplies Rybelsus® (oral semaglutide) 3 mg, 7 mg and 14 mg tablets to hospitals and pharmacies in India. Contact us for current availability.
What does Rybelsus contain?
Rybelsus contains semaglutide, marketed by Novo Nordisk. The details of use are those on its label.
Can I order a single pack?
A.K. Pharma is a distributor and supplies bulk/wholesale quantities only, not one or two pieces.
How should Rybelsus be stored?
Keep it in the original blister pack as directed on the carton, away from moisture and light.
Is Rybelsus an injection?
No. It is an oral semaglutide tablet, unlike the semaglutide injections in the same family.
Does A.K. Pharma advise on dosing or suitability?
No. Treatment decisions, including dosing, rest solely with the treating physician and the approved prescribing information.
How do I request a quote?
Call or WhatsApp us, or use the contact details below.
📍 E-2/257A, 2nd Floor, Shastri Nagar, New Delhi 110052
📞 011 4172 6999
📱 WhatsApp: +91 9810034827
🌐 akpharma.in
Disclaimer: This page is intended for informational and sourcing/procurement purposes only and does not constitute medical or clinical advice. A.K. Pharma is a licensed medicine distributor, not a healthcare provider, and does not provide clinical guidance. All treatment decisions, including drug selection and dosing, rest solely with the treating physician and should follow the approved prescribing information.
